New search Hide text from Guidelines
C CARDIOVASCULAR SYSTEMThis group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.
C10 LIPID MODIFYING AGENTS
| The DDDs are based on the treatment of hypercholesterolemia. |
C10A LIPID MODIFYING AGENTS, PLAIN
Pantethine, which is also used in the treatment of hyperlipidemi, is classified as a vitamin in A11HA.
C10AX Other lipid modifying agents
This group comprises all cholesterol and triglyceride reducers, which cannot be classified in the preceding groups.
Icosapent ethyl is classified in C10AX06 - omega-3-triglycerides incl. other esters and acids.
Sulodexide is classified in B01AB.
| The DDD for evolocumab is based on dosing every second week. The DDD for volanesorsen is based on the treatment of familial chylomicronemia syndrome. |
| ATC code | Name | DDD | U | Adm.R | Note |
| C10AX07 | magnesium pyridoxal 5-phosphate glutamate |
Last updated: 2024-01-26